Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.63
-0.17-4.47%
Bicycle Therapeutics PLC (BCYC) Stock Price, Quote, News & History
BCYCNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Bicycle Therapeutics has a consensus price target of $20.38.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $3.8 last updated .
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
